STADA Group

STADA Group is a global pharmaceutical company based in Bad Vilbel, Germany, with a history that dates back to 1895. The company operates under a three-pillar strategy focusing on consumer healthcare products, generics, and specialty pharmaceuticals. STADA's products are available in approximately 120 countries, and it generated revenues of around €4.06 billion in 2024. The company develops and manufactures a wide range of generic drugs, providing cost-effective alternatives to branded medicines. Its consumer healthcare portfolio includes well-known OTC brands such as Grippostad-C, Silomat, and Ladival. STADA also emphasizes specialty pharmaceuticals, including biosimilars and personalized drug therapies, supported by advanced research and development. With a global network of manufacturing sites and logistics centers, STADA ensures efficient product delivery to pharmacies, healthcare providers, and consumers worldwide. The company is committed to innovation and quality, aiming to meet diverse healthcare needs across its international markets.